Ms. Fatma Elsayed is a young researcher in the field of biochemistry and molecular biology, currently engaged in advanced studies and research focused on the therapeutic potential of natural and nano-formulated compounds in mitigating drug-induced toxicity and cancer progression. Her work primarily investigates molecular mechanisms underlying oxidative stress, inflammation, and signal transduction pathways in disease models. As a research assistant at the National Research Center in Egypt, she has gained extensive expertise in nanomaterial imaging using Transmission Electron Microscopy (TEM), molecular biology techniques such as RNA extraction, PCR, and ELISA, and analytical instrumentation including HPLC and mass spectrophotometry. She has contributed to peer-reviewed publications addressing cardiotoxicity and neurotoxicity induced by chemotherapeutic agents, as well as nanoparticle-based interventions in oncology. Beyond her research, she has practical experience as an oncology and community pharmacist, providing medication management and patient education on safe drug use and antimicrobial resistance. Her academic achievements have been recognized through national awards and a competitive scholarship from the Academy of Scientific Research and Technology. In addition to her scientific pursuits, she has demonstrated leadership in organizing academic conferences and mentoring peers in scientific writing. With a solid foundation in pharmaceutical sciences, molecular pharmacology, and nanotechnology, Ms. Elsayed continues to pursue innovative biomedical research aimed at improving therapeutic efficacy and patient outcomes in cancer and toxicology-related studies.

Profile: Google Scholar

Featured Publication

Elsayed, F. F., Elshenawy, W. M., Khalifa, E. M., Rizq, M. R., & Abdelaziz, R. R. (2022). Ameliorative effect of flavocoxid on cyclophosphamide-induced cardio and neurotoxicity via targeting the GM-CSF/NF-κB signaling pathway. Environmental Science and Pollution Research, 29(46), 69635–69651.